<GlossaryTerm id="CDR0000760577"><TermName>Purixan</TermName><TermPronunciation>(PYOOR-ee-zan)</TermPronunciation><TermDefinition><DefinitionText>A drug used with other drugs to treat adults and children with acute lymphoblastic leukemia. It is also being studied in the treatment of other types of cancer. Purixan stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called mercaptopurine and Purinethol.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000762441" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Purixan&quot;" language="en" id="_3"/><MediaLink ref="CDR0000762440" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Purixan&quot;" language="es" id="_4"/><SpanishTermName>Purixan</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa con otros medicamentos para el tratamiento de adultos y niños con leucemia linfoblástica aguda. También está en estudio para el tratamiento de otros tipos de cáncer. Purixan impide que las células elaboren ADN y es posible que destruya células cancerosas. Es un tipo de antimetabolito. También se llama mercaptopurina y Purinetol.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-05-01</DateFirstPublished><DateLastModified>2020-12-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000749756" url="/about-cancer/treatment/drugs/mercaptopurine">Mercaptopurine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
